Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, Sillano F, Buttarelli M, Piermattei A, Loverro M, Camarda F, Greco V, De Bonis M, Minucci A, Gallo D, Urbani A, Vizzielli G, Scambia G, Sette C. Cesari E, et al. Among authors: piermattei a. J Exp Clin Cancer Res. 2023 May 18;42(1):126. doi: 10.1186/s13046-023-02682-5. J Exp Clin Cancer Res. 2023. PMID: 37202753 Free PMC article.
Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease.
Santoro A, Angelico G, Piermattei A, Inzani F, Valente M, Arciuolo D, Spadola S, Mulè A, Zorzato P, Fagotti A, Scambia G, Zannoni GF. Santoro A, et al. Among authors: piermattei a. Front Oncol. 2019 Aug 19;9:778. doi: 10.3389/fonc.2019.00778. eCollection 2019. Front Oncol. 2019. PMID: 31482065 Free PMC article.
PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients.
Battaglia A, Piermattei A, Buzzonetti A, Pasciuto T, Zampetti N, Fossati M, Angelico G, Iacobelli V, Nero C, Iannucci V, Scambia G, Fagotti A, Fattorossi A. Battaglia A, et al. Among authors: piermattei a. Cancers (Basel). 2021 Oct 16;13(20):5200. doi: 10.3390/cancers13205200. Cancers (Basel). 2021. PMID: 34680346 Free PMC article.
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma.
Arciuolo D, Travaglino A, Santoro A, Scaglione G, D'Alessandris N, Valente M, Inzani F, Accarino R, Piermattei A, Benvenuto R, Raffone A, Nero C, Pelligra S, Fanfani F, Mascolo M, Zannoni GF. Arciuolo D, et al. Among authors: piermattei a. Cancers (Basel). 2022 Jul 26;14(15):3635. doi: 10.3390/cancers14153635. Cancers (Basel). 2022. PMID: 35892892 Free PMC article.
What's beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study.
Perrone E, Tudisco R, Pafundi PC, Guido D, Ciucci A, Martinelli E, Zannoni GF, Piermattei A, Spadola S, Ferrante G, Marchetti C, Scambia G, Fagotti A, Gallo D. Perrone E, et al. Among authors: piermattei a. Cancers (Basel). 2022 Sep 22;14(19):4588. doi: 10.3390/cancers14194588. Cancers (Basel). 2022. PMID: 36230510 Free PMC article.
187 results